Oramed Pharmaceuticals Inc (ORMP) Stock Price

3.035 ▲ +0.135 (+4.66%)
Open: 2.90 Vol: 920.33K Day's range: 2.86 - 3.1399 Dec 11, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ORMP Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 3.03▼ 3.01▲ 3.04▼ 2.80▲ 2.70▲
MA10 3.02▲ 3.04▼ 3.00▲ 2.78▲ 2.51▲
MA20 3.04▼ 2.94▲ 2.87▲ 2.66▲ 2.38▲
MA50 2.88▲ 2.81▲ 2.79▲ 2.48▲ 2.29▲
MA100 2.81▲ 2.79▲ 2.69▲ 2.36▲ 2.39▲
MA200 2.81▲ 2.61▲ 2.51▲ 2.29▲ 3.68▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.009▼ -0.003▼ 0.019▲ 0.020▲ 0.069▲
RSI 56.177▲ 62.571▲ 64.560▲ 73.396▲ 68.345▲
STOCH 52.680     39.250     79.488     50.420     61.801    
WILL %R -50.000     -27.778     -18.072▲ -14.204▲ -9.991▲
CCI 38.095     32.969     65.789     207.215▲ 197.539▲
Latest Filters Detected On ORMP
▲ PSAR&MOM $ORMP PSAR Switch Up + Momentum Set Alert
▲ RSI $ORMP RSI(14) Crossed Above 70 Set Alert
▲ BREAK $ORMP Price Breaks 60 Days High Set Alert
▲ BREAK $ORMP Price Breaks 30 Days High Set Alert
▲ BREAK $ORMP Price Breaks 20 Days High Set Alert
▲ BREAK $ORMP Price Breaks 10 Days High Set Alert
Oramed Pharmaceuticals Inc News
ORMP: Advancing Clinical Activities, Generating Gains From Investment Portfolio, New Rights Plan Adopted
Monday, November 24, 2025 10:26 AM
ORMP READ THE FULL ORMP RESEARCH REPORT ADVANCING ORMD-0801 THROUGH CLINICAL STUDIES Trial will focus on key patient subpopulations that have responded to ORMD-0801 following analysis of earlier trial ...
Oramed Reports Fiscal Third Quarter 2025 Financial Results
Monday, November 17, 2025 05:57 AM
Strong Nine-Month Performance Driven by Strategic Investment Portfolio; Total Assets Increase 42% to $220.5 Million NEW YORK, Nov. 17, 2025 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) ...
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
Sunday, November 16, 2025 09:49 PM
NEW YORK, Nov. 17, 2025 /PRNewswire/ -- The Board of Directors of Oramed Pharmaceuticals Inc. (the "Company") announced today that it has unanimously adopted a Rights Agreement, dated November 17, ...
ORMP historical stock data
date open high low close volume
11/12/25 2.90 3.1399 2.86 3.035 920,330
10/12/25 2.70 2.92 2.69 2.90 241,365
09/12/25 2.70 2.77 2.665 2.68 40,659
08/12/25 2.66 2.77 2.66 2.69 57,474
05/12/25 2.70 2.75 2.6702 2.69 55,552
04/12/25 2.72 2.75 2.69 2.72 62,265
03/12/25 2.73 2.76 2.715 2.72 90,511
02/12/25 2.70 2.8364 2.69 2.75 154,041
01/12/25 2.80 2.80 2.6788 2.75 119,918
28/11/25 2.85 2.89 2.75 2.85 162,998
Quote Details
52wk Low:1.82
52wk High:3.14
Vol:920.33K
Avg Vol(3m):3.2M
1Y Chng:+28.06%
1M Chng:+26.46%
Add to Watch List
More Information
Index US Composite
Market Cap. 120.94M